Study in sentence

3604 examples of Study in a sentence

And the Essex study which has just been done in the U.K., which incidentally showed that when you do this, you do not just make a room that's suitable for hearing-impaired children, you make a room where behavior improves, and results improve significantly, this found that sending a child out of area to a school that does have such a room, if you don't have one, costs 90,000 pounds a year.

Out of that conference, incidentally, also came a free app which is designed to help children study if they're having to work at home, for example, in a noisy kitchen.

It's a study at Harvard where, at the end of the study, they're going to take my entire genomic sequence, all of my medical information, and my identity, and they're going to post it online for everyone to see.

But like DIYbio, the positive outcomes and the potential for good for a study like that far outweighs the risk.

I study prejudice, and I teach at a competitive business school, so it was inevitable that I would become interested in power dynamics.

I actually came across this fascinating study by the Pew Center this week that revealed that an active Facebook user is three times as likely as a non-Internet user to believe that most people are trustworthy.

We can now use human beings to study and model the software in human beings, and we have a few burgeoning biological measures.

We can study individual dyads.

We can study the way that one person interacts with another person, turn the numbers up, and start to gain new insights into the boundaries of normal cognition, but more importantly, we can put people with classically defined mental illnesses, or brain damage, into these social interactions, and use these as probes of that.

The economist Robert Jensen did this wonderful study a while back where he watched, in great detail, what happened to the fishing villages of Kerala, India, when they got mobile phones for the very first time.

So firstly, thinking just about precognition, as it turns out, just last year a researcher called Daryl Bem conducted a piece of research where he found evidence of precognitive powers in undergraduate students, and this was published in a peer-reviewed academic journal and most of the people who read this just said, "Okay, well, fair enough, but I think that's a fluke, that's a freak, because I know that if I did a study where I found no evidence that undergraduate students had precognitive powers, it probably wouldn't get published in a journal.

And in fact, we know that that's true, because several different groups of research scientists tried to replicate the findings of this precognition study, and when they submitted it to the exact same journal, the journal said, "No, we're not interested in publishing replication.

So in 1980, some researchers did a study on a drug called lorcainide, and this was an anti-arrhythmic drug, a drug that suppresses abnormal heart rhythms, and the idea was, after people have had a heart attack, they're quite likely to have abnormal heart rhythms, so if we give them a drug that suppresses abnormal heart rhythms, this will increase the chances of them surviving.

Now actually, in 1993, the researchers who did that 1980 study, that early study, published a mea culpa, an apology to the scientific community, in which they said, "When we carried out our study in 1980, we thought that the increased death rate that occurred in the lorcainide group was an effect of chance."

The development of lorcainide was abandoned for commercial reasons, and this study was never published; it's now a good example of publication bias.

I read the one study that was published that showed that reboxetine was better than placebo, and I read the other three studies that were published that showed that reboxetine was just as good as any other antidepressant, and because this patient hadn't done well on those other antidepressants, I thought, well, reboxetine is just as good.

In fact, there have been so many studies conducted on publication bias now, over a hundred, that they've been collected in a systematic review, published in 2010, that took every single study on publication bias that they could find.

If I conducted one study and I withheld half of the data points from that one study, you would rightly accuse me, essentially, of research fraud.

And when they tried to get a hold of the clinical study reports, the 10,000-page long documents that have the best possible rendition of the information, they were told they weren't allowed to have them.

In 2008, a study was conducted which showed that half of all of trials published by journals edited by members of the ICMJE weren't properly registered, and a quarter of them weren't registered at all.

And in the BMJ, in the first edition of January, 2012, you can see a study which looks to see if people kept to that ruling, and it turns out that only one in five have done so.

In the question of consciousness and artificial intelligence, artificial intelligence has really, like the study of consciousness, gotten nowhere, we have no idea how consciousness works.

It's the idea that agreement to join a study without understanding isn't agreement.

It's something that protects us from harm, from hucksters, from people that would try to hoodwink us into a clinical study that we don't understand, or that we don't agree to.

And so you put together the thread of narrative hypothesis, experimentation in humans, and informed consent, and you get what we call clinical study, and it's how we do the vast majority of medical work.

Clinical studies form the basis of how we investigate, so if we're going to look at a new drug, right, we test it in people, we draw blood, we do experiments, and we gain consent for that study, to make sure that we're not screwing people over as part of it.

But the world is changing around the clinical study, which has been fairly well established for tens of years if not 50 to 100 years.

You interact with your doctor and you get enrolled in the study.

People you don't know come in and look at you and poke you and prod you, and when I tell cancer survivors that this tool we created to protect them is actually preventing their data from being used, especially when only three to four percent of people who have cancer ever even sign up for a clinical study, their reaction is not, "Thank you, God, for protecting my privacy."

So Vanderbilt ran a study asking people, we'd like to take your biosamples, your blood, and share them in a biobank, and only five percent of the people opted out.

Related words